Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.
William T. Beck(University of Illinois Chicago), N A Brophy(Stanford University), Susan E. Bates(The Nature Conservancy), Deo Kumar Srivastava(St. Jude Children's Research Hospital), Randy D. Gascoyne(BC Cancer Agency), David M. Parham(Children's Hospital of Los Angeles), Antonio Tito Fojo, William S. Dalton(Texas Oncology), Cheryl L. Willman(Mayo Clinic), Manfred Dietel(Humboldt-Universität zu Berlin), M. Lehnert(Merck & Co., Inc., Rahway, NJ, USA (United States)), Peter J. Houghton(The University of Texas at San Antonio Health Science Center), John F. Kuttesch(St. Jude Children's Research Hospital), Michael Andreeff(The University of Texas MD Anderson Cancer Center), Elisabeth Paietta(Montefiore Medical Center), Carlos Cordon‐Cardo(Icahn School of Medicine at Mount Sinai), Catherine P. Leith(University of Wisconsin Carbone Cancer Center), Helen S. L. Chan(Ontario Institute for Cancer Research), Henk J. Broxterman(Vrije Universiteit Amsterdam), Costan W. Berard(National Cancer Institute), James M. Boyett(University of Illinois Chicago), Zlatko P. Pavelić(University of Cincinnati), David Head, Thomas M. Grogan
PubMed
July 1, 1996
Cited by 388
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
A multigenic program mediating breast cancer metastasis to bone
|Cancer Cell|2003|2.6k